Quantinuum Inc

Aktienanalyse zu Quantinuum Inc (QNT)

$49.920

-3.774 (-7.56%)Zum Schluss

Loading chart…
High
54.140
Open
53.695
VWAP
51.24
Vol
1.48M
Mkt Cap
Low
49.650
Amount
76.03M
EV/EBITDA, TTM
-2.89

Quantinuum Inc. is a provider of quantum computing platform, which offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property. The Company's vertically integrated quantum computing platform combines quantum hardware systems and middleware with application software designed to make quantum computing deployable in real-world environments built on the Quantum Charge‑Coupled Device architecture. Its products and solutions include Quantinuum Systems, Helios, Quantum Origin, InQuanto and Nexus. Nexus is a quantum computing platform for accessing and managing performance full stack. InQuanto is a quantum computational chemistry for complex molecular and materials simulations. Quantum Origin is a quantum random number generator designed for encryption and protect data. Its developer tools include TKET, Guppy and Lambeq. It operates across pharmaceuticals, materials science, financial services, government and industrial markets.

AI analysis of Quantinuum Inc (QNT)

sell

Quantinuum Inc. is not a good buy right now due to significant financial losses and declining stock performance. The current price is $49.92, with a staggering net loss of $596.5 million in Q2 2026 and a year-to-date change of -16.80%. While analysts have set price targets as high as $155, the company's recent performance and high volatility present considerable risks.

Bewertungskennzahlen

The current forward P/E ratio for Quantinuum Inc (QNT) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
-17.04
Current EV/EBITDA
-2.89
Überbewertet
-8.57
Unterbewertet
-25.52

Forward P/S

Strongly Undervalued
5Y Average P/S
350.38
Current P/S
233.67
Überbewertet
407.80
Unterbewertet
292.96

Whales holding QNT

G

Granahan Investment Management, LLC

+ HoldingQNT

+12.25%

3M Return

I

Insight Venture Management, LLC

+ HoldingQNT

+8.16%

3M Return

P

Penserra Capital Management LLC

+ HoldingQNT

+7.29%

3M Return

J

Jain Global LLC

+ HoldingQNT

+1.40%

3M Return

S

Seven Grand Managers LLC

+ HoldingQNT

-6.64%

3M Return

B

Burkehill Global Management, LP

+ HoldingQNT

-8.72%

3M Return

Event-Zeitleiste

2026-08-12 (ET)

17:00:00

Dow Jones Index Dips Slightly as CPI Report Meets Expectations

16:00:00

Quantinuum Partners with Oracle for Quantum Computing

15:00:00

Anthropic Signs $9.1B Data Center Deal with Riot

12:30:00

Quantinuum Stock Rises 21.2% to $67.92

12:30:00

Major U.S. Averages Edge Higher as CPI Report Meets Expectations

News

QNT FAQ — answered by Alphio AI

Quantinuum Inc. is a provider of quantum computing platform, which offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property. The Company's vertically integrated quantum computing platform combines quantum hardware systems and middleware with application software designed to make quantum computing deployable in real-world environments built on the Quantum Charge‑Coupled Device architecture. Its products and solutions include Quantinuum Systems, Helios, Quantum Origin, InQuanto and Nexus. Nexus is a quantum computing platform for accessing and managing performance full stack. InQuanto is a quantum computational chemistry for complex molecular and materials simulations. Quantum Origin is a quantum random number generator designed for encryption and protect data. Its developer tools include TKET, Guppy and Lambeq. It operates across pharmaceuticals, materials science, financial services, government and industrial markets. It operates in the Technology sector.

Quantinuum Inc. is not a good buy right now due to significant financial losses and declining stock performance. The current price is $49.92, with a staggering net loss of $596.5 million in Q2 2026 and a year-to-date change of -16.80%. While analysts have set price targets as high as $155, the company's recent performance and high volatility present considerable risks.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten